Logo-jcvtr
Submitted: 20 Dec 2021
Revision: 29 Mar 2022
Accepted: 18 Aug 2022
ePublished: 30 Aug 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Cardiovasc Thorac Res. 2022;14(3): 166-171.
doi: 10.34172/jcvtr.2022.29
PMID: 36398046
PMCID: PMC9617056
Scopus ID: 85140373491
  Abstract View: 736
  PDF Download: 371
  Full Text View: 145

Original Article

Preoperative atrial fibrillation predicts worse outcomes after LVAD implantation

Moritz Benjamin Immohr 1 ORCID logo, Yukiharu Sugimura 1* ORCID logo, Esma Yilmaz 1, Hug Aubin 1 ORCID logo, Udo Boeken 1 ORCID logo, Payam Akhyari 1 ORCID logo, Artur Lichtenberg 1 ORCID logo, Hannan Dalyanoglu 1

1 Department of Cardiac Surgery, University Hospital of Düsseldorf, Düsseldorf, Germany
*Corresponding Author: Corresponding Author: Yukiharu Sugimura, Email: , Email: Yukiharu.Sugimura@med.uni-duesseldorf.de

Abstract

Introduction: Left ventricular assist device (LVAD) implantation is a common therapy for end-stage heart failure. Heart failure patients often present with atrial fibrillation (AF). The purpose of this study was to evaluate the influence of preoperative AF as well as vascular complications on outcome in LVAD patients.

Methods: Between 01/2010 and 12/2017, 168 patients (141 male) with end-stage heart failure underwent LVAD implantation at a single center. Patient outcome was retrospectively studied by using the Kaplan-Meier method for analyzing crude survival as well as Cox regression for analyzing risk factors.

Results: Sixty-two patients suffered from preoperative atrial fibrillation at LVAD implantation. Mean age was 56.8±11.9 years (range: 22–79) and 141 (84%) were male. Postoperative vascular or visceral surgical management due to malperfusion was needed in 27 patients (16.1%) and did not correlate with postoperative mortality (P=0.121, HR=1.587, CI=0.885–2.845). Patients with preoperative AF had a worse outcome in the Kaplan-Meier analysis (P=0.069). In contrast, cox regression showed that postoperative AF could not to be considered to be an independent predictor of mortality in this study group.

Conclusion: Our data suggest that preoperative AF may be a potential predictor of mortality and impaired long-term outcome in LVAD patients. In contrast, preoperative ECLS and vascular or visceral surgery after LVAD implantation did not represent limiting factors with regard to mortality after LVAD implantation.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 737

Your browser does not support the canvas element.


PDF Download: 371

Your browser does not support the canvas element.


Full Text View: 145

Your browser does not support the canvas element.